Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!

INVEST: Older patients with CAD had better outcomes with systolic BP target <140 mm Hg

25.08.20141929
These results call into question the JNC 8 panel recommendation to relaxsystolic BP targets to <150 mm Hg for patients aged 60 and older, according to the researchers.

Impact of eight weeks of repeated ischaemic preconditioning on brachial artery and cutaneous microcirculatory function in healthy males

22.08.20141613
Ischaemic preconditioning has well-established cardiac and vascular protective effects. Short interventions (one week) of daily ischaemic preconditioning episodes improve conduit and microcirculatory function.

Eliquis OK'd for Treating, Preventing VTE

22.08.20141853
The FDA has approved the oral anticoagulant drug apixaban for treating deep vein thrombosis and pulmonary embolism and for preventing recurrent episodes of these conditions, according to the two firms selling the drug.

2nd Cardiovascular Disease Prevention conference, Morocco

21.08.20142622
Scientific programme endorsed by the European Association for Cardiovascular Prevention and Rehabilitation (EACPR), a registered branch of the European Society of Cardiology (ESC).

World Sleep Day 2014: Results

20.08.20142158
At the end of summer Committee of the World Sleep Day summarized results of the Best Event Contest dedicated to this day.

Incidence of sick sinus syndrome projected to double within 50 years

20.08.20141680
The incidence of sick sinus syndrome in the United States is projected to double in the next 50 years, with increased risk specifically in older and white adults.

Fenofibrate cut adverse CV outcomes in women with diabetes by one-third

19.08.20141695
Women with type 2 diabetes and already at risk for heart disease had a 30% reduction in adverse cardiovascular outcomes with the cholesterol-lowering.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.